Archive for January, 2009

Key Component In Cell Replication Identified By Stanford Scientists

Last week, a presidential limousine shuttled Barack Obama to the most important job in his life. Scientists at the Stanford University School of Medicine have now identified a protein that does much the same for the telomerase enzyme – ferrying the critically important clump of proteins around to repair the ends of chromosomes that are lost during normal replication. Without such ongoing maintenance, stem cells would soon cease dividing and embryos would fail to develop.

Early-Stage Multiple Sclerosis Reversed By Stem Cell Transplant

Researchers from Northwestern University’s Feinberg School of Medicine appear to have reversed the neurological dysfunction of early-stage multiple sclerosis patients by transplanting their own immune stem cells into their bodies and thereby “resetting” their immune systems. “This is the first time we have turned the tide on this disease,” said principal investigator Richard Burt, M.D. chief of immunotherapy for autoimmune diseases at the Feinberg School.

StemCellPatents.com Applauds International Stem Cell Corporation (ISCO) On Recent Developments

StemCellPatents.com, an organization that covers recent news in stem cell therapeutics and has assembled the only comprehensive index of all issued U.S. stem cell patents, congratulates International Stem Cell Corporation (OTCBB:ISCO) on its recent developments, including being the first company to grow human corneal tissue from stem cells.

Cord Blood America Announces Expansion Plans For Its Stem Cell Storage Program

Cord Blood America, Inc. (OTCBB: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that it intends a rapid expansion of its health insurance partnership program to new geographies in 2009.

Stem Cell Transplant Trial Results – Comment By The Multiple Sclerosis Society

Ahead of the publication on Friday 30 January of a paper in The Lancet Neurology reporting the results of a trial involving stem cell transplantation in people with relapsing remitting multiple sclerosis (MS), please find below a comment from the MS Society:

Scientists Reverse Early MS With Patients' Own Stem Cells

A small trial at a US hospital where patients with early stage MS had their own immune system stem cells transplanted back into their bodies appears to have reversed the neurological dysfunction of the early stages of the disease by causing their immune systems to “reset”. The scientists said the results should now be confirmed with a larger, randomized trial.

Health Buzz: Obama and Stem Cells and Other Health News

Pfizer and Wyeth, an end to the abortion funding ban.

What Stem Cells Can Do—and Can't

Stem cell promise new disease treatments but haven’t yet delivered.

Health Buzz: Avoiding Care-giver Abuse and Other Health News

First stem-cell test and detox products for the skin.